- Volume 28 Issue 1
DOI QR Code
Comparative Study of the Effects of the Retrocrural Celiac Plexus Block Versus Splanchnic Nerve Block, C-arm Guided, for Upper Gastrointestinal Tract Tumors on Pain Relief and the Quality of Life at a Six-month Follow Up
- Shwita, Amera H. (Department of Anesthesia and Pain Relief, Tanta Cancer Institute) ;
- Amr, Yasser Mohamed. (Department of Anesthesia and Surgical Intensive Care, Faculty of Medicine, Tanta University) ;
- Okab, Mohammad I. (Department of Anesthesia and Surgical Intensive Care, Faculty of Medicine, Tanta University)
- Received : 2014.09.11
- Accepted : 2014.11.17
- Published : 2015.01.01
Background: The celiac plexus and splanchnic nerves are targets for neurolytic blocks for pain relief from pain caused by upper gastrointestinal tumors. Therefore, we investigated the analgesic effect of a celiac plexus block versus a splanchnic nerve block and the effects of these blocks on the quality of life six months post-intervention for patients with upper GIT tumors. Methods: Seventy-nine patients with inoperable upper GIT tumors and with severe uncontrolled visceral pain were randomized into two groups. These were Group I, for whom a celiac plexus block was used with a bilateral needle retrocrural technique, and Group II, for whom a splanchnic nerve block with a bilateral needle technique was used. The visual analogue scale for pain (0 to 100), the quality of life via the QLQ-C30 questionnaire, and survival rates were assessed. Results: Pain scores were comparable in both groups in the first week after the block. Significantly more patients retained good analgesia with tramadol in the splanchnic group from 16 weeks onwards (P = 0.005, 0.001, 0.005, 0.001, 0.01). Social and cognitive scales improved significantly from the second week onwards in the splanchnic group. Survival of both groups was comparable. Conclusions: The results of this study demonstrate that the efficacy of the splanchnic nerve block technique appears to be clinically comparable to a celiac block. All statistically significant differences are of little clinical value.
- Caraceni A, Portenoy RK. Pain management in patients with pancreatic carcinoma. Cancer 1996; 78: 639-53. https://doi.org/10.1002/(SICI)1097-0142(19960801)78:3+<639::AID-CNCR9>3.3.CO;2-N
- Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995; 61: 277-84. https://doi.org/10.1016/0304-3959(94)00178-H
- de Oliveira R, dos Reis MP, Prado WA. The effects of early or late neurolytic sympathetic plexus block on the management of abdominal or pelvic cancer pain. Pain 2004; 110: 400-8. https://doi.org/10.1016/j.pain.2004.04.023
- Firdousi FH, Sharma D, Raina VK. Palliation by coeliac plexus block for upper abdominal visceral cancer pain. Trop Doct 2002; 32: 224-6. https://doi.org/10.1177/004947550203200413
- Mercadante S, Catala E, Arcuri E, Casuccio A. Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. J Pain Symptom Manage 2003; 26: 1140-7. https://doi.org/10.1016/j.jpainsymman.2003.04.004
- Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114: 29-36. https://doi.org/10.1016/j.pain.2004.12.010
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76. https://doi.org/10.1093/jnci/85.5.365
- Lawlor P, Turner K, Hanson J, Bruera E. Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study. Pain 1997; 72: 79-85. https://doi.org/10.1016/S0304-3959(97)00018-3
- Breitbart W, Chandler S, Eagel B, Ellison N, Enck RE, Lefkowitz M, et al. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain. Oncology (Williston Park) 2000; 14: 695-705.
- Goudas L, Carr DB, Bloch R, Balk E, Ioannidis JP, Terrin N, et al. Management of cancer pain. Evid Rep Technol Assess (Summ) 2001: 1-5.
- Noble M, Gress FG. Techniques and results of neurolysis for chronic pancreatitis and pancreatic cancer pain. Curr Gastroenterol Rep 2006; 8: 99-103. https://doi.org/10.1007/s11894-006-0004-x
- Okuyama M, Shibata T, Morita T, Kitada M, Tukahara Y, Fukushima Y, et al. A comparison of intraoperative celiac plexus block with pharmacological therapy as a treatment for pain of unresectable pancreatic cancer. J Hepatobiliary Pancreat Surg 2002; 9: 372-5. https://doi.org/10.1007/s005340200042
- Loukas M, Klaassen Z, Merbs W, Tubbs RS, Gielecki J, Zurada A. A review of the thoracic splanchnic nerves and celiac ganglia. Clin Anat 2010; 23: 512-22. https://doi.org/10.1002/ca.20964
- Peterson PK, Molitor TW, Chao CC. The opioid-cytokine connection. J Neuroimmunol 1998; 83: 63-9. https://doi.org/10.1016/S0165-5728(97)00222-1
- Kawamata M, Ishitani K, Ishikawa K, Sasaki H, Ota K, Omote K, et al. Comparison between celiac plexus block and morphine treatment on quality of life in patients with pancreatic cancer pain. Pain 1996; 64: 597-602. https://doi.org/10.1016/0304-3959(95)00189-1
- Stefaniak T, Basinski A, Vingerhoets A, Makarewicz W, Connor S, Kaska L, et al. A comparison of two invasive techniques in the management of intractable pain due to inoperable pancreatic cancer: neurolytic celiac plexus block and videothoracoscopic splanchnicectomy. Eur J Surg Oncol 2005; 31: 768-73. https://doi.org/10.1016/j.ejso.2005.03.012
- Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993; 217: 447-55. https://doi.org/10.1097/00000658-199305010-00004
- Cherry DA, Lamberty J. Paraplegia following coeliac plexus block. Anaesth Intensive Care 1984; 12: 59-61.
- Stafford B. More complications of coeliac plexus blockade. Aust N Z J Med 1991; 21: 782-3.
- Davies DD. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med 1993; 86: 264-6.
- Sastre B, Carabalona B, Crespy B, Delpero JR, Sielezneff I, Michotey G. Transhiatal bilateral splanchnicotomy for pain control in pancreatic cancer: basic anatomy, surgical technique, and immediate results in fifty-one cases. Surgery 1992; 111: 640-6.
- Raj PP, Thomas J, Heavner J, Racz G, Lou L, Day M, et al. The development of a technique for radiofrequency lesioning of splanchnic nerves. Curr Rev Pain 1999; 3: 377-87. https://doi.org/10.1007/s11916-999-0080-3
- Saenz A, Kuriansky J, Salvador L, Astudillo E, Cardona V, Shabtai M, et al. Thoracoscopic splanchnicectomy for pain control in patients with unresectable carcinoma of the pancreas. Surg Endosc 2000; 14: 717-20. https://doi.org/10.1007/s004640000185
- Suleyman Ozyalcin N, Talu GK, Camlica H, Erdine S. Efficacy of coeliac plexus and splanchnic nerve blockades in body and tail located pancreatic cancer pain. Eur J Pain 2004; 8: 539-45. https://doi.org/10.1016/j.ejpain.2004.01.001
- Marra V, Debernardi F, Frigerio A, Menna S, Musso L, Di Virgilio MR. Neurolytic block of the celiac plexus and splanchnic nerves with computed tomography. The experience in 150 cases and an optimization of the technic. Radiol Med 1999; 98: 183-8.
- Gangi A, Dietemann JL, Schultz A, Mortazavi R, Jeung MY, Roy C. Interventional radiologic procedures with CT guidance in cancer pain management. Radiographics 1996; 16: 1289-304. https://doi.org/10.1148/radiographics.16.6.8946536